News
-
EP PerMed at the 5th African Health Research and Innovation Funders Forum (AHRIFF)
Around 70 representatives of grant-making institutions, African government and public funding agencies, philanthropic organisations, development finance institutions and regional banks came together at the 5th AHRIFF meeting in Cape Town, South Africa, from 5-7 November. The aim was to create greater alignment between funding agencies investing in Africa and improve understanding of Africa’s health priorities.
-
New Best Practice Example: Regional Healthcare Information Platform in Halland, Sweden
EP PerMed has recently awarded the title of “Best Practice” (BP) in Personalised Medicine to the Regional Healthcare Information Platform in Halland, Sweden. As an integrated healthcare system, Region Halland has committed to fact-based provision, development and research supported by the wealth of data continuously generated in digitalised healthcare. For more than a decade, Region Halland has built…
-
New Best Practice Example: Childhood Cancer in Sweden
EP PerMed awards the title of Best Practice in Personalised Medicine to Genomic Medicine Sweden (GMS) for their national implementation of whole-genome and -transcriptome sequencing in childhood cancer in Sweden (GMS Childhood Cancer). GMS Childhood Cancer is dedicated to ensuring that every child diagnosed with cancer in Sweden has access to the most accurate and personalised diagnostics and…
-
RITC2026 Information Day – Recording & Slides available
The RITC2026 will fund innovation projects in human health that focus on multimodal data usage for personalised medicine approaches providing more efficient and personalised management of multimorbid patients, having at least two chronic diseases that require management. A call information day was organised on 28 October 2025. The recording and slides are now available.
EP PerMed RITC2026
Test and Demonstration of Multimodal Data Approaches for Personalised Medicine
EP PerMed will fund innovation projects in human health that focus on multimodal data usage for personalised medicine approaches providing more efficient and personalised management of patients with multimorbidity, having at least two chronic diseases that require management
Citizen Awareness of Personalised Medicine
Your opinion matters!
Have you been involved in a personalised treatment or are you aware of personalised medicine approaches?
EP PerMed likes to understand how well people are informed about personalised medicine, how they perceive it, and their thoughts on its potential benefits and challenges.
The anonymous survey contains 36 questions and takes approximately 10-15 minutes to complete. It is currently available in: English, Czech, Danish, Finnish, French, German, Greek, Italian, Norwegian, Dutch, Polish, Portuguese, Romanian, Spanish, Swedish and Turkish.
Mission & Objectives
Governance & Boards
The European Partnership for Personalised Medicine gathers together around 60 partners from 25 countries. The Consortium is managed by a so-called Coordination Unit (CU) and General Assembly (GeA). The day-to-day business, planning and implementation of activities is realized through five Work Packages. The EP PerMed overarching Advisory Bodies are ICPerMed, an Advisory Board and a Stakeholder Forum.